The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.
Carbapenems: Past, Present, and Future
Open accessAbstract
In this review, we summarize the current “state of the art” of carbapenem antibiotics and their role in our antimicrobial armamentarium. Among the β-lactams currently available, carbapenems are unique because they are relatively resistant to hydrolysis by most β-lactamases, in some cases act as “slow substrates” or inhibitors of β-lactamases, and still target penicillin binding proteins. This “value-added feature” of inhibiting β-lactamases serves as a major rationale for expansion of this class of β-lactams. We describe the initial discovery and development of the carbapenem family of β-lactams. Of the early carbapenems evaluated, thienamycin demonstrated the greatest antimicrobial activity and became the parent compound for all subsequent carbapenems. To date, more than 80 compounds with mostly improved antimicrobial properties, compared to those of thienamycin, are described in the literature. We also highlight important features of the carbapenems that are presently in clinical use: imipenem-cilastatin, meropenem, ertapenem, doripenem, panipenem-betamipron, and biapenem. In closing, we emphasize some major challenges and urge the medicinal chemist to continue development of these versatile and potent compounds, as they have served us well for more than 3 decades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Self-citationYong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Multidrug efflux pumps of gram-negative bacteria
Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.20.5853-5859.1996 · Cited by 1,082
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
Tipper, D. J., & Strominger, J. L. (1965) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.54.4.1133 · Cited by 1,008
Comparative Review of the Carbapenems
Zhanel, G. G., Wiebe, R., Dilay, L., Thomson, K., Rubinstein, E., Hoban, D. J., Noreddin, A. M., & Karlowsky, J. A. (2007) · Drugs · doi:10.2165/00003495-200767070-00006 · Cited by 652
Active Efflux and Diffusion Are Involved in Transport of Pseudomonas aeruginosa Cell-to-Cell Signals
Pearson, J. P., Van Delden, C., & Iglewski, B. H. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1203-1210.1999 · Cited by 631
KAHAN, J. S., KAHAN, F. M., GOEGELMAN, R., CURRIE, S. A., JACKSON, M., STAPLEY, E. O., MILLER, T. W., MILLER, A. K., HENDLIN, D., MOCHALES, S., et al. (1979) · The Journal of Antibiotics · doi:10.7164/antibiotics.32.1 · Cited by 514
Emerging carbapenemases: a global perspective
Walsh, T. R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(10)70004-2 · Cited by 506
Bebrone, C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.021 · Cited by 505
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Hugonnet, J.-E., Tremblay, L. W., Boshoff, H. I., Barry, C. E., & Blanchard, J. S. (2009) · Science · doi:10.1126/science.1167498 · Cited by 494
Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.563 · Cited by 450
Three-dimensional structure of the bacterial cell wall peptidoglycan
Meroueh, S. O., Bencze, K. Z., Hesek, D., Lee, M., Fisher, J. F., Stemmler, T. L., & Mobashery, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510182103 · Cited by 415
Naturally-occurring beta-lactamase inhibitors with antibacterial activity
BROWN, A. G., BUTTERWORTH, D., COLE, M., HANSCOMB, G., HOOD, J. D., READING, C., & ROLINSON, G. N. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.668 · Cited by 399
Perron, K., Caille, O., Rossier, C., van Delden, C., Dumas, J.-L., & Köhler, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312080200 · Cited by 358
Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
Kropp, H., Sundelof, J. G., Hajdu, R., & Kahan, F. M. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.1.62 · Cited by 339
Function of Pseudomonas Porins in Uptake and Efflux
Hancock, R. E. W., & Brinkman, F. S. L. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160310 · Cited by 319
Paterson, D. L. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00107.x · Cited by 310
Carbapenemases: Molecular Diversity and Clinical Consequences
Poirel, L., Pitout, J. D., & Nordmann, P. (2007) · Future Microbiology · doi:10.2217/17460913.2.5.501 · Cited by 309
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-09 · Cited by 307
The assembled structure of a complete tripartite bacterial multidrug efflux pump
Symmons, M. F., Bokma, E., Koronakis, E., Hughes, C., & Koronakis, V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900693106 · Cited by 292
Trias, J., & Nikaido, H. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.1.52 · Cited by 291
Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Köhler, T., Michea-Hamzehpour, M., Epp, S. F., & Pechere, J.-C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.424 · Cited by 268
Acinetobacter baumannii: a universal threat to public health?
Giamarellou, H., Antoniadou, A., & Kanellakopoulou, K. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.02.013 · Cited by 258
Akama, H., Matsuura, T., Kashiwagi, S., Yoneyama, H., Narita, S.-I., Tsukihara, T., Nakagawa, A., & Nakae, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400164200 · Cited by 255
Garau, G., Bebrone, C., Anne, C., Galleni, M., Frère, J.-M., & Dideberg, O. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.070 · Cited by 231
Fernandez-Cuenca, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg097 · Cited by 229
Ochs, M. M., McCusker, M. P., Bains, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1085 · Cited by 214
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01410-08 · Cited by 211
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Bayés, M., Rabasseda, X., & Prous, J. (2002) · PubMed · Cited by 200
The Challenges of Antimicrobial Resistance in Brazil
Rossi, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir120 · Cited by 183
Extended-spectrum β-lactamases and the permeability barrier
Martínez-Martínez, L. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01860.x · Cited by 177
Docquier, J.-D., Calderone, V., De Luca, F., Benvenuti, M., Giuliani, F., Bellucci, L., Tafi, A., Nordmann, P., Botta, M., Rossolini, G. M., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.04.010 · Cited by 176
Riera, E., Cabot, G., Mulet, X., Garcia-Castillo, M., del Campo, R., Juan, C., Canton, R., & Oliver, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr232 · Cited by 175
Risk Factors for Acquisition of Imipenem-Resistant Acinetobacter baumannii : a Case-Control Study
Lee, S.-O., Kim, N. J., Choi, S.-H., Kim, T. H., Chung, J.-W., Woo, J.-H., Ryu, J., & Kim, Y. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.224-228.2004 · Cited by 175
Two decades of imipenem therapy
Rodloff, A. C., Goldstein, E. J. C., & Torres, A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl354 · Cited by 171
Crystal structure of the class D beta-lactamase OXA-10.
Strynadka, N. C. J., Paetzel, M., Danel, F., de Castro, L., Mosimann, S. C., & Page, M. G. P. (2000) · Nature Structural Biology · doi:10.1038/79688 · Cited by 161
Maveyraud, L., Mourey, L., Kotra, L. P., Pédelacq, J. D., Guillet, V., Mobashery, S., & Samama, J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9818001 · Cited by 149
Mena, A., Plasencia, V., García, L. M., Hidalgo, O., Ayestarán, I., Albertí, S., Borrell, N., Pérez, J. L., & Oliver, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00418-06 · Cited by 148
Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases ,
Ke, W., Bethel, C. R., Thomson, J. M., Bonomo, R. A., & van den Akker, F. (2007) · Biochemistry · doi:10.1021/bi700300u · Cited by 144
Self-citationCarbapenems in clinical practice: a guide to their use in serious infection
Bradley, J. S., Garau, J., Lode, H., Rolston, K. V., Wilson, S. E., & Quinn, J. P. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00094-6 · Cited by 140
Nicasio, A. M., Kuti, J. L., & Nicolau, D. P. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.2.235 · Cited by 139
SQ 27,860, a simple carbapenem produced by species of Serratia and Erwinia.
Parker, W. L., Rathnum, M. L., WELLS, J. J. S., TREJO, W. H., Principe, P. A., & SYKES, R. B. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.653 · Cited by 135
Galleni, M., Amicosante, G., & Frère, J.-M. (1988) · Biochemical Journal · doi:10.1042/bj2550123 · Cited by 134
Siroy, A., Molle, V., Guillier, C., Vallenet, D., Pestel‐Caron, M., Cozzone, A. J., Jouenne, T., & Dé, E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4876-4883.2005 · Cited by 132
Stapleton, P. D., Shannon, K. P., & French, G. L. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1206 · Cited by 131
Status report on carbapenemases: challenges and prospects
Patel, G., & Bonomo, R. A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.28 · Cited by 131
Self-citationShahid, M., Sobia, F., Singh, A., Malik, A., Khan, H. M., Jonas, D., & Hawkey, P. M. (2009) · Critical Reviews in Microbiology · doi:10.1080/10408410902733979 · Cited by 131
Santillana, E., Beceiro, A., Bou, G., & Romero, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607557104 · Cited by 127
Emergence of imipenem resistance in clinical Escherichia coli during therapy
Oteo, J., Delgado‐Iribarren, A., Vega, D., Bautista, V., Rodríguez, M. C., Velasco, M., Saavedra, J. M., Pérez-Vázquez, M. D., García-Cobos, S., Martínez-Martínez, L., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.012 · Cited by 117
Spratt, B. G., Jobanputra, V., & Zimmermann, W. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.3.406 · Cited by 110
Rodríguez-Hernández, M. J., Pachón, J., Pichardo, C., et al. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.493 · Cited by 110
New developments in carbapenems
Kattán, J. N., Villegas, M. V., & Quinn, J. P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02101.x · Cited by 107
Petrella, S., Gelus, N., Mayer, C., Renard, M., Jarlier, V., & Sougakoff, W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-08 · Cited by 106
Armand-Lefèvre, L., Leflon‐Guibout, V., Bredin, J., Barguellil, F., Amor, A., Pagès, J., & Nicolas-Chanoine, M.-H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1165-1168.2003 · Cited by 102
Modugno, E. D., Erbetti, I., Ferrari, L., Galassi, G., Hammond, S. M., & Xerri, L. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2362 · Cited by 100
Queenan, A. M., Shang, W., Flamm, R. K., & Bush, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01004-09 · Cited by 99
Tremblay, L. W., Fan, F., & Blanchard, J. S. (2010) · Biochemistry · doi:10.1021/bi100232q · Cited by 97
Perry, C. M., & Ibbotson, T. (2002) · Drugs · doi:10.2165/00003495-200262150-00005 · Cited by 97
Jacqueline, C., Navas, D., Batard, E., Miegeville, A.-F., Le Mabecque, V., Kergueris, M.-F., Bugnon, D., Potel, G., & Caillon, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.45-51.2005 · Cited by 95
Pankuch, G. A., Lin, G., Seifert, H., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-07 · Cited by 95
The Biosynthetic Gene Cluster for the β-Lactam Carbapenem Thienamycin in Streptomyces cattleya
Núñez, L. E., Méndez, C., Braña, A. F., Blanco, G., & Salas, J. A. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00069-3 · Cited by 93
Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins
Raimondi, A., Traverso, A., & Nikaido, H. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1174 · Cited by 89
Huang, H., & Hancock, R. E. W. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.11.3085-3090.1996 · Cited by 88
Cartwright, S. J., & Waley, S. G. (1983) · Medicinal Research Reviews · doi:10.1002/med.2610030402 · Cited by 87
Swarén, P., Maveyraud, L., Raquet, X., Cabantous, S., Duez, C., Pédelacq, J. D., Mariotte-Boyer, S., Mourey, L., Labia, R., Nicolas-Chanoine, M.-H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26714 · Cited by 85
Mammeri, H., Nordmann, P., Berkani, A., & Eb, F. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01126.x · Cited by 83
Assembly and transport mechanism of tripartite drug efflux systems
Misra, R., & Bavro, V. N. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.017 · Cited by 82
Hashizume, T., Ishino, F., Nakagawa, J., Tamaki, S., & Matsuhashi, M. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.394 · Cited by 82
Schneider, K. D., Ortega, C. J., Renck, N. A., Bonomo, R. A., Powers, R. A., & Leonard, D. A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.042 · Cited by 78
Self-citationNukaga, M., Bethel, C. R., Thomson, J. M., Hujer, A. M., Distler, A. M., Anderson, V. E., Knox, J. R., & Bonomo, R. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7111146 · Cited by 78
Self-citationImipenem and expression of multidrug efflux pump in Enterobacter aerogenes
Bornet, C., Chollet, R., Malléa, M., Chevalier, J., Davin‐Regli, A., Pagès, J., & Claude Bollet, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00074-3 · Cited by 78
Structural Basis for Imipenem Inhibition of Class C β-Lactamases
Beadle, B. M., & Shoichet, B. K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3978-3980.2002 · Cited by 78
Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa
Hirakata, Y., Kondo, A., Hoshino, K., et al. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.06.007 · Cited by 77
Catalytic Mechanism of Class B2 Metallo-β-lactamase
Xu, D., Xie, D., & Guo, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512517200 · Cited by 76
Elucidating the role of Trp105 in the KPC‐2 β‐lactamase
Papp‐Wallace, K. M., Taracila, M. A., Wallace, C. J., Hujer, K. M., Bethel, C. R., Hornick, J. M., & Bonomo, R. A. (2010) · Protein Science · doi:10.1002/pro.454 · Cited by 76
Self-citationChow, J. W., & Shlaes, D. M. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.4.499 · Cited by 74
Farra, A., Islam, S., Strålfors, A., Sörberg, M., & Wretlind, B. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.016 · Cited by 73
Pernot, L., Frénois, F., Rybkine, T., L’Hermite, G., Petrella, S., Delettré, J., Jarlier, V., Collatz, E., & Sougakoff, W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4805 · Cited by 71
Easton, C. J., & Knowles, J. R. (1982) · Biochemistry · doi:10.1021/bi00541a008 · Cited by 71
Frase, H., Shi, Q., Testero, S. A., Mobashery, S., & Vakulenko, S. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011262 · Cited by 70
Charnas, R. L., & Knowles, J. R. (1981) · Biochemistry · doi:10.1021/bi00513a005 · Cited by 69
Current concepts in antibiotic-resistant Gram-negative bacteria
Torres, J. A., Villegas, M. V., & Quinn, J. P. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.833 · Cited by 67
Membrane topology and site‐specific mutagenesis of Pseudomonas aeruginosa porin OprD
Huang, H., Jeanteur, D., Pattus, F., & Hancock, R. E. W. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02319.x · Cited by 66
In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones
Rodríguez, C. H., Ambrosio, A. D., Bajuk, M., Spinozzi, M., Nastro, M., Bombicino, K. A., Radice, M. A., Gutkind, G., Vay, C. A., & Famiglietti, A. M. R. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.604 · Cited by 63
The 1.4 Å Crystal Structure of the Class D β-Lactamase OXA-1 Complexed with Doripenem
Schneider, K. D., Karpen, M. E., Bonomo, R. A., Leonard, D. A., & Powers, R. A. (2009) · Biochemistry · doi:10.1021/bi901690r · Cited by 62
Self-citationCommon Mechanistic Features among Metallo-β-lactamases
Simona, F., Magistrato, A., Peraro, M. D., Cavalli, A., Vila, A. J., & Carloni, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049502 · Cited by 59
Tomillero, A., & Moral, M. A. (2008) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2008.30.5.1236622 · Cited by 59
Evolution of β-Lactamase Inhibitors
Rolinson, G. N. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_9.s727 · Cited by 58
Souli, M., Rekatsina, P. D., Chryssouli, Z., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-08 · Cited by 57
Mechanism of turnover of imipenem by the TEM .beta.-lactamase revisited
Taibi, P., & Mobashery, S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00134a003 · Cited by 55
Efflux Pump Inhibitors: A Strategy to Combat P‐Glycoprotein and the NorA Multidrug Resistance Pump
Zhang, L., & Ma, S. (2010) · ChemMedChem · doi:10.1002/cmdc.201000006 · Cited by 54
Papp‐Wallace, K. M., Taracila, M. A., Hornick, J. M., Hujer, A. M., Hujer, K. M., Distler, A. M., Endimiani, A., & Bonomo, R. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00197-10 · Cited by 53
Self-citationCirioni, O., Ghiselli, R., Silvestri, C., Kamysz, W., Orlando, F., Mocchegiani, F., Matteo, F. D., Riva, A., Łukasiak, J., Scalise, G., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01576-06 · Cited by 53
Comparative activity of carbapenem testing: the COMPACT study
Nordmann, P., Picazo, J. J., Mutters, R., Korten, V., Quintana, A., Laeuffer, J., Seak, J. C. H., Flamm, R. K., Morrissey, I., on behalf of the COMPACT study group, et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr056 · Cited by 53
Sumita, Y., & Fakasawa, M. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.1.53 · Cited by 52
Structure of the imipenem-hydrolyzing class A β-lactamase SME-1 fromSerratia marcescens
Sougakoff, W., L’Hermite, G., Pernot, L., Naas, T., Guillet, V., Nordmann, P., Jarlier, V., & Delettré, J. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901019606 · Cited by 52
Hikida, M., Itahashi, K., Igarashi, A., Shiba, T., & Kitamura, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2010 · Cited by 52
Noncovalent interaction energies in covalent complexes: TEM‐1 β‐lactamase and β‐lactams
Wang, X., Minasov, G., & Shoichet, B. K. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10058 · Cited by 51
Kotsakis, S. D., Miriagou, V., Tzelepi, Ε., & TZOUVELEKIS, L. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00771-10 · Cited by 51
Fukuoka, T., Ohya, S., Narita, T., Katsuta, M., Iijima, M., Masuda, N., Yasuda, H., Trias, J., & Nikaido, H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.322 · Cited by 51
Metallo-β-lactamase inhibitory activity of phthalic acid derivatives
Hiraiwa, Y., Morinaka, A., Fukushima, T., & Kudo, T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.018 · Cited by 50
Antibiotic-related nephrotoxicity.
Kaloyanides, G. J. (1994) · PubMed · Cited by 50
Nunes, S., Sá‐Leão, R., Pereira, L., & de LENCASTRE, H. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01871.x · Cited by 49
BASKER, M. J., Boon, R. J., & Hunter, P. (1980) · The Journal of Antibiotics · doi:10.7164/antibiotics.33.878 · Cited by 49
Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries
Minond, D., Saldanha, S. A., Subramaniam, P. S., Spaargaren, M., Spicer, T., Fotsing, J. R., Weide, T., Fokin, V. V., Sharpless, K. B., Galleni, M., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.070 · Cited by 48
Endimiani, A., Luzzaro, F., Pini, B., Amicosante, G., Rossolini, G. M., & Toniolo, A. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-52 · Cited by 46
Self-citationEnhancing Resistance to Cephalosporins in Class C β-Lactamases: Impact of Gly214Glu in CMY-2
Endimiani, A., Doi, Y., Bethel, C. R., Taracila, M. A., Adams‐Haduch, J. M., O’Keefe, A., Hujer, A. M., Paterson, D. L., Skalweit, M. J., Page, M. G. P., et al. (2009) · Biochemistry · doi:10.1021/bi9015549 · Cited by 46
Self-citationDrawz, S. M., Babić, M. S., Bethel, C. R., Taracila, M., Distler, A. M., Ori, C., Caselli, E., Prati, F., & Bonomo, R. A. (2009) · Biochemistry · doi:10.1021/bi9015988 · Cited by 46
Self-citationLakaye, B., Dubus, A., Lepage, S., Groslambert, S., & Frère, J. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01150.x · Cited by 44
Villar, H. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.365 · Cited by 44
Zafaralla, G. C., & Mobashery, S. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00030a070 · Cited by 43
Amino Acid Residues That Contribute to Substrate Specificity of Class A β-Lactamase SME-1
Majiduddin, F. K., & Palzkill, T. G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3421-3427.2005 · Cited by 43
Specific Labeling of Peptidoglycan Precursors as a Tool for Bacterial Cell Wall Studies
van Dam, V., Olrichs, N. K., & Breukink, E. J. (2009) · ChemBioChem · doi:10.1002/cbic.200800678 · Cited by 42
New agents in development for the treatment of bacterial infections
Abbanat, D., Morrow, B. J., & Bush, K. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.001 · Cited by 42
Carbapenem resistance in a clinical isolate of Citrobacter freundii
Mainardi, J., Mugnier, P., Coutrot, A., Buu-Hoï, A., Collatz, E., & Gutmann, L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2352 · Cited by 42
Asparenomycins A, B and C, new carbapenem antibiotics. III. Structures.
Tsuji, N., NAGASHIMA, K., Kobayashi, M., SHOJI, J., Kato, T., Terui, Y., Nakai, H., & Shiro, M. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.24 · Cited by 42
Involvement of two related porins, OprD and OpdP, in the uptake of arginine byPseudomonas aeruginosa
Tamber, S., & Hancock, R. E. W. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00293.x · Cited by 41
In Vitro Activity of LK-157, a Novel Tricyclic Carbapenem As Broad-Spectrum β-Lactamase Inhibitor
Paukner, S., Hesse, L., Preželj, A., Šolmajer, T., & Urleb, U. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00085-08 · Cited by 41
Exploring the Inhibition of CTX-M-9 by β-Lactamase Inhibitors and Carbapenems
Bethel, C. R., Taracila, M. A., Shyr, T., Thomson, J. M., Distler, A. M., Hujer, K. M., Hujer, A. M., Endimiani, A., Papp‐Wallace, K. M., Bonnet, R., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00089-11 · Cited by 40
Self-citationGiske, C. G., Buarø, L., Sundsfjord, A., & Wretlind, B. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0778 · Cited by 39
Cerquetti, M., Giufrè, M., Cardines, R., & Mastrantonio, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00335-07 · Cited by 38
The structures of pluracidomycins, new carbapenem antibiotics.
Tsuji, N., NAGASHIMA, K., Kobayashi, M., Terui, Y., Matsumoto, K., & KONDO, E. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.536 · Cited by 38
Carbapenems and SHV-1 β-Lactamase Form Different Acyl-Enzyme Populations in Crystals and Solution
Kalp, M., & CAREY, P. R. (2008) · Biochemistry · doi:10.1021/bi800833u · Cited by 37
Costello, A. L., Sharma, N. P., Yang, K., Crowder, M. W., & Tierney, D. L. (2006) · Biochemistry · doi:10.1021/bi061547e · Cited by 37
An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates
Mahamoud, A., Chevalier, J., Baitiche, M., Adam, E., & Pagès, J. (2010) · Microbiology · doi:10.1099/mic.0.045716-0 · Cited by 37
Plantan, I., Selič, L., Mesar, T., Anderluh, P. Š., Oblak, M., Preželj, A., Hesse, L., Andrejašič, M., Vilar, M., Turk, D., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0703237 · Cited by 36
Tune, B. M. (1994) · PubMed · Cited by 36
How Epileptogenic are the Recent Antibiotics?
Hantson, P., Léonard, F., Maloteaux, J. M., & Mahieu, P. (1999) · Acta Clinica Belgica · doi:10.1080/17843286.1999.11754213 · Cited by 35
Ayala, J. A., Quesada, A., Vadillo, S., Criado, J., & Píriz, S. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45930-0 · Cited by 35
Asparenomycins A, B and C, new carbapenem antibiotics. V. Inhibition of .BETA.-lactamases.
Murakami, K., Doi, M., & Yoshida, T. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.39 · Cited by 33
Imipenem as substrate and inhibitor of β-lactamases
Monks, J., & Waley, S. G. (1988) · Biochemical Journal · doi:10.1042/bj2530323 · Cited by 32
Approaches to the simultaneous inactivation of metallo- and serine-β-lactamases
Ganta, S., Perumal, S. K., Pagadala, S. R. R., Samuelsen, Ø., SPENCER, J. M., Pratt, R. F., & Buynak, J. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.018 · Cited by 32
Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia
Chouchani, C., Marrakchi, R., & Salabi, A. A. E. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.552880 · Cited by 31
Safety of Meropenem in Patients Reporting Penicillin Allergy: Lack of Allergic Cross Reactions
Cunha, B. A., Hamid, N. S., Krol, V., & Eisenstein, L. E. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.2.233 · Cited by 31
Paterson, D. L. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.36446 · Cited by 28
Chronic hepatitis C infection and insulin resistance: two best friends
Abenavoli, L., & Almasio, P. L. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.72 · Cited by 22
Vilar, M., Galleni, M., Šolmajer, T., Turk, B., Frère, J., & Matagne, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2215-2223.2001 · Cited by 22
Design, synthesis and bioactivity evaluation of tribactam β lactamase inhibitors
Čopar, A., Prevec, T., Anžič, B., Mesar, T., Selič, L., Vilar, M., & Šolmajer, T. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00061-6 · Cited by 17
Combination Effect of Teicoplanin and Various Antibiotics against Hetero-VRSA and VRSA
Hanaki, H., & HIRAMATSU, K. (1999) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi1970.73.1048 · Cited by 12
Force, E., Taberner, F., Cabellos, C., Ribes, S., Domenech, A., Tubau, F., Viladrich, P. F., & Gudiol, F. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0711-y · Cited by 7
Sanchez, P. A., TONEY, J. H., Thomas, J. D., & Berger, J. M. (2009) · Assay and Drug Development Technologies · doi:10.1089/adt.2008.167 · Cited by 3
Stam, J. G. (2000) · Kirk-Othmer Encyclopedia of Chemical Technology · doi:10.1002/0471238961.1201032019200113.a01 · Cited by 2
Cited by
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
David, S., Reuter, S., Harris, S. R., Glasner, C., Feltwell, T., Argimon, S., Abudahab, K., Goater, R., Giani, T., Errico, G., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0492-8 · Cited by 773
Carbapenem Resistance: A Review
Codjoe, F., & Donkor, E. (2017) · Medical Sciences · doi:10.3390/medsci6010001 · Cited by 746
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Metallo‐β‐lactamase structure and function
Palzkill, T. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06796.x · Cited by 505
Metadata
- Authors
- Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2011-11
- Volume
- 55
- Issue
- 11
- Pages
- 4943-4960
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2123677996
- Cited by
- 1,502
- References
- 148
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.